Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia
Name
Heiman-2014-Molecular adaptation.pdf
Size
1.04 MB
Format
Adobe PDF
Checksum (MD5)
a75f06bc855b5b218bba02d0d652f525
Author(s) • • • • • • • • •
Heiman, Myriam
Heilbut, Adrian
Francardo, Veronica
Kulicke, Ruth
Fenster, Robert
Kolaczyk, Eric D.
Mesirov, Jill P.
Surmeier, Dalton J.
Cenci, M. Angela
Greengard, Paul
Date Issued
March 2014
Journal
Proceedings of the National Academy of Sciences
Publisher
National Academy of Sciences (U.S.)
Citation
Heiman, M., A. Heilbut, V. Francardo, R. Kulicke, R. J. Fenster, E. D. Kolaczyk, J. P. Mesirov, D. J. Surmeier, M. A. Cenci, and P. Greengard. “Molecular Adaptations of Striatal Spiny Projection Neurons During Levodopa-Induced Dyskinesia.” Proceedings of the National Academy of Sciences 111, no. 12 (March 5, 2014): 4578–4583.
Version
Final published version
Abstract
Levodopa treatment is the major pharmacotherapy for Parkinson's disease. However, almost all patients receiving levodopa eventually develop debilitating involuntary movements (dyskinesia). Although it is known that striatal spiny projection neurons (SPNs) are involved in the genesis of this movement disorder, the molecular basis of dyskinesia is not understood. In this study, we identify distinct cell-type–specific gene-expression changes that occur in subclasses of SPNs upon induction of a parkinsonian lesion followed by chronic levodopa treatment. We identify several hundred genes, the expression of which is correlated with levodopa dose, many of which are under the control of activator protein-1 and ERK signaling. Despite homeostatic adaptations involving several signaling modulators, activator protein-1–dependent gene expression remains highly dysregulated in direct pathway SPNs upon chronic levodopa treatment. We also discuss which molecular pathways are most likely to dampen abnormal dopaminoceptive signaling in spiny projection neurons, hence providing potential targets for antidyskinetic treatments in Parkinson's disease.
MIT Department
Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
Picower Institute for Learning and Memory
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1073/pnas.1401819111